Efectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine and lamivudine in HIV-1-infected adults in Cameroon: Open-label multicentre trial. Laurent C, Kovanfack C, Koulla-Shiro S, Nikové N et al. Lancet 2004; 364: 29-34
Guardado en:
Autor principal: | |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Chilena de Infectología
2004
|
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182004000400013 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0716-10182004000400013 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0716-101820040004000132005-04-14Efectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine and lamivudine in HIV-1-infected adults in Cameroon: Open-label multicentre trial. Laurent C, Kovanfack C, Koulla-Shiro S, Nikové N et al. Lancet 2004; 364: 29-34Calvo A.,Marioinfo:eu-repo/semantics/openAccessSociedad Chilena de InfectologíaRevista chilena de infectología v.21 n.4 20042004-12-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182004000400013es10.4067/S0716-10182004000400013 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
Spanish / Castilian |
author |
Calvo A.,Mario |
spellingShingle |
Calvo A.,Mario Efectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine and lamivudine in HIV-1-infected adults in Cameroon: Open-label multicentre trial. Laurent C, Kovanfack C, Koulla-Shiro S, Nikové N et al. Lancet 2004; 364: 29-34 |
author_facet |
Calvo A.,Mario |
author_sort |
Calvo A.,Mario |
title |
Efectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine and lamivudine in HIV-1-infected adults in Cameroon: Open-label multicentre trial. Laurent C, Kovanfack C, Koulla-Shiro S, Nikové N et al. Lancet 2004; 364: 29-34 |
title_short |
Efectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine and lamivudine in HIV-1-infected adults in Cameroon: Open-label multicentre trial. Laurent C, Kovanfack C, Koulla-Shiro S, Nikové N et al. Lancet 2004; 364: 29-34 |
title_full |
Efectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine and lamivudine in HIV-1-infected adults in Cameroon: Open-label multicentre trial. Laurent C, Kovanfack C, Koulla-Shiro S, Nikové N et al. Lancet 2004; 364: 29-34 |
title_fullStr |
Efectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine and lamivudine in HIV-1-infected adults in Cameroon: Open-label multicentre trial. Laurent C, Kovanfack C, Koulla-Shiro S, Nikové N et al. Lancet 2004; 364: 29-34 |
title_full_unstemmed |
Efectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine and lamivudine in HIV-1-infected adults in Cameroon: Open-label multicentre trial. Laurent C, Kovanfack C, Koulla-Shiro S, Nikové N et al. Lancet 2004; 364: 29-34 |
title_sort |
efectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine and lamivudine in hiv-1-infected adults in cameroon: open-label multicentre trial. laurent c, kovanfack c, koulla-shiro s, nikové n et al. lancet 2004; 364: 29-34 |
publisher |
Sociedad Chilena de Infectología |
publishDate |
2004 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182004000400013 |
work_keys_str_mv |
AT calvoamario efectivenessandsafetyofagenericfixeddosecombinationofnevirapinestavudineandlamivudineinhiv1infectedadultsincameroonopenlabelmulticentretriallaurentckovanfackckoullashirosnikovenetallancet20043642934 |
_version_ |
1718440067094020096 |